Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab)3件: Ocrelizumab,
Ofatumumab (Ofatumumabum),
Rituximab
3件: Rituximab ,
Ocrelizumab ,
Ofatumumab (Ofatumumab) 💬
1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
2ArzerraProduct Name: ofatumumabProduct Code: OMB157Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: OFATUMUMABCAS Number: 679818-59-8Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useTrade Name: KesimptaProduct Name: ofatumumabProduct Code: OMB157Pharmaceutical Form: Solution for injection in pre-filled penINN or Proposed INN: OFATUMUMABCAS Number: 679818-59-8Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 50-----1件: 13 💬
3Combination Product: ofatumumab with AI1件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
4Combination Product: ofatumumab with PRF1件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
5Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab12件: Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab (Ofatumumabum),
Ponesimod,
Rituximab,
Teriflunomide
13件: Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Fingolimod hydrochloride ,
Glatiramer acetate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab (Ofatumumab),
Fingolimod ,
Teriflunomide ,
Ponesimod ,
Fingolimod lauryl sulfate 💬
26件: DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬
58件: Allograft rejection, Antigen processing and presentation, Arrhythmogenic right ventricular cardiomyopathy, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Phagocytosis, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬1件: 13 💬
6Ofatumumab1件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬6件: 11, 13, 35, 46, 222, 223 💬
7Ofatumumab 1001件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
8Ofatumumab 3001件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
9Ofatumumab 30mg1件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
10Ofatumumab 3mg1件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
11Ofatumumab 60mg1件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
12Ofatumumab 7001件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
13Ofatumumab approved dose1件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
14Ofatumumab new dose1件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
15Ofatumumab subcutaneous injection1件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 13, 35 💬
16Other: Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq8件: Alemtuzumab,
Cladribine,
Hyaluronidase,
Natalizumab,
Ocrelizumab,
Ofatumumab (Ofatumumabum),
Rituximab,
Ublituximab
10件: Cladribine ,
Alemtuzumab ,
Rituximab ,
Hyaluronidase ,
Hyaluronidase ,
Ocrelizumab ,
Hyaluronidase ,
Natalizumab ,
Ofatumumab (Ofatumumab),
Ublituximab 💬
3件: ITGA4,
MS4A1,
RRM1 💬
21件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Focal adhesion, Glutathione metabolism, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
17Other: Ofatumumab1件: Ofatumumab (Ofatumumabum)1件: Ofatumumab (Ofatumumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬